글로벌 무침주입 시스템 시장 – 2030년까지의 산업 동향 및 예측

바늘 없는 주입 시스템 시장 분석 및 규모

무침 주입 시스템은 기존 바늘로 피부를 뚫지 않고 환자에게 액상 제형, 약물 및 백신을 투여하는 데 사용됩니다. 이러한 시스템에 대한 수요는 백신 에 대한 면역 반응을 개선하고 , 바늘 위험을 없애고, 의료비를 절감하기 때문에 최근 몇 년 동안 상당히 증가했습니다.

Data Bridge Market Research는 2022년에 1억 5,600만 달러였던 무침주사 시스템 시장이 2030년까지 6억 7,077만 달러에 도달할 것으로 예상되며 예측 기간 동안 20.00%의 CAGR을 보일 것으로 분석했습니다. 이는 시장 가치를 나타냅니다. 액체 기반 무침주사기는 약물 투여에 대한 수요가 증가함에 따라 무침주사 시스템 시장의 유형 세그먼트를 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

바늘 없는 주사 시스템 시장 범위 및 세분화

시장 정의

무침 주입 시스템은 기존 바늘로 피부를 뚫지 않고 환자에게 액상 제형, 약물 및 백신을 투여하는 데 사용됩니다. 이러한 시스템에 대한 수요는 백신에 대한 면역 반응을 개선하고, 바늘 위험을 제거하고, 의료비를 절감하기 때문에 최근 몇 년 동안 상당히 증가했습니다. 그러나 숙련된 전문가가 부족하고 정맥 투여를 위한 무침 주입 시스템의 사용이 제한되어 시장 성장이 방해를 받고 있습니다.

글로벌 무침주입 시스템 시장 동향

운전자

• 환자 증가 추세와 시장 성장을 촉진하기 위한 치료 촉진

약물은 가능한 한 편리하고 고통 없이 주사 바늘을 사용하지 않고 신체에 투여되어야 합니다. 바늘 없는 주사 시스템은 다양한 질환을 치료하기 위해 약물을 투여하는 데 사용됩니다. 예측 기간 동안 골다공증과 당뇨병을 포함한 만성 질환의 유병률이 증가함에 따라 바늘 없는 주사 시스템 시장의 가치가 증가할 것으로 추산됩니다.

무침주사 시스템은 기존 바늘로 피부를 뚫지 않고도 다양한 약물을 환자에게 주입하는 새로운 방식입니다.

• 연구 및 개발 능력

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to medical devices and advance products will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical instruments is also expected to drive the market growth rate.

When developing drug-delivery device systems, it is important to identify equipment that can efficiently perform all of the required product testing while intelligently capturing and evaluating the test data in accordance with government regulations. The test system must also be flexible and modular enough that manufacturers can change and add functionality over time.

• Increasing Government Initiatives for Improving Healthcare

Healthcare sector is increasing rapidly, which have a significant impact on public health as well as economic activity. The increasing government initiatives for advance systems enhance the demand for the Needle Free Injection Systems. The use of Needle Free Injection Systems is increasing in households, hospitals and independent laboratory.

When developing and mass producing such devices, manufacturers usually perform a combination of testing to government-regulated standards and internal quality testing to ensure efficacy of the device. Internal quality testing is often necessary because the international standards committees cannot always amend testing standards as quickly as the device technology evolves.

Opportunities

• Increasing Demand for Painless Drug Delivery

Needle-free injections provide a painless alternative to traditional needle injections, which can be particularly beneficial for patients who have a fear of needles or experience discomfort during injections. The market is expected to grow as more individuals seek painless drug delivery options.

• Expansion of Vaccination Programs

Needle-free injection systems are also being widely adopted in vaccination programs, particularly in developing countries. They offer advantages such as reduced cross-contamination risk and improved vaccine coverage. As global vaccination programs continue to expand, the demand for needle-free injection devices is expected to rise.

Restraints/Challenges

• Limited Awareness and Acceptance

The needle-free injection technology is still relatively new and not as widely known or accepted compared to traditional needle injections. Healthcare providers and patients may have concerns about the efficacy, safety, and reliability of these devices, which could hinder their adoption.

• High Cost of Products

Needle-free injection devices can be more expensive compared to traditional needle-based injection systems. The initial investment and ongoing maintenance costs associated with these devices may limit their adoption, particularly in low-income regions or healthcare settings with budget constraints.

This Needle Free Injection Systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global needle free injection systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In March 2022, NovaXS Biotech launch injection therapy needle-free such as NovaXS Biotech wants to make injection therapy needle-free
• In December 2021, PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next-generation DNA-based COVID-19 vaccine candidates
• In August 2021, PharmaJet partner Zydus Cadila announced Emergency Use Authorization approval for worlds first plasmid DNA COVID-19 vaccine deliver via needle-free injection

Global Needle Free Injection Systems Market Scope

The Needle Free Injection Systems market is segmented on the type, product, technology, usability, site of delivery, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Liquid-Based Needle-Free Injectors
• Projectile/Depot-Based Needle-Free Injectors
• Powder-Based Needle Free Injectors

Product

• Fillable Needle-Free Injectors
• Prefilled Needle-Free Injectors

Technology

• Jet-Based Needle-Free Injectors
• Spring Global Needle Free Injectors
• Laser-Powered Needle-Free Injectors
• Vibration-Based Needle-Free Injectors

Usability

• Disposable Needle-Free Injectors
• Reusable Needle-Free Injectors

Site of Delivery

• Subcutaneous Injectors
• Intramuscular Injectors
• Intradermal Injectors

Application

• Vaccine Delivery
• Insulin Delivery
• Oncology​​​​​​​
• Pain Management
• Other

End User

• Hospitals and Clinics
• Home Care Settings
• Research Laboratories
• Pharmaceutical and Biotechnological Companies
• Other

Global Needle Free Injection Systems Market Regional Analysis/Insights

The global Needle Free Injection Systems market is analysed and market size insights and trends are provided by country, type, product, technology, usability, site of delivery, application and end user as referenced above.

The countries covered in the Needle Free Injection Systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global needle free injection systems market because of the strong base of healthcare facilities, the strong presence of major players in the market increases cases of chronic diseases, and the rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global needle free injection systems market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global needle free injection systems market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global needle free injection systems market. The data is available for the historic period 2015-2020.

Competitive Landscape and Global Needle Free Injection Systems Market Share Analysis

글로벌 무침 주입 시스템 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭 및 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 글로벌 무침 주입 시스템 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 무침주사 시스템 시장에서 활동하는 주요 기업은 다음과 같습니다.

• PharmaJet(미국)
• 포털 인스트루먼트(미국)
• Medical International Technology, Inc (미국)
• NuGen 의료기기(캐나다)
• 크로스젝트 SA(미국)
• 안타레스파마(미국)
• 3M(미국)
• 인젝스 파마 AG(독일)
• NovaXS Biotech(미국)
• INVIO Pharmaceutical Inc. (미국)

SKU-21353